At the news
? BEARISHIMPACT 7/10 8-K filed May 8, 2026 at 16:24 ET
Artiva Biotherapeutics priced a $300M underwritten public offering of 23.9M shares and pre-funded warrants for 2.2M shares at $11.52 per share, equating to roughly 100% dilution of existing shares. The massive capital raise signals urgent cash needs for a pre-revenue biotech and will severely dilute existing shareholders.
- Offering of 23,871,526 shares and 2,170,138 pre-funded warrants for common stock
- Price: $11.52 per share; $11.5199 per pre-funded warrant
- Gross proceeds approximately $300 million
- Closing expected May 11, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access